Summary Eicosapentaenoic acid (EPA) has been shown to have an inhibitory effect on the growth of several pancreatic cancer cell lines in vitro. This study investigates the mechanism of growth inhibition and cytotoxicity of EPA on the pancreatic cancer cell line MIA PaCa-2. Cells were analysed for cell count, viability, cell cycle distribution and ultrastructural changes. There was a time-and dose-dependent decrease in cell count and viability in cultures of pancreatic cancer cells supplemented with EPA. Flow cytometric DNA anlaysis of MIA PaCa-2 cells incubated with EPA demonstrated the presence of sub G1 populations corresponding to the presence of apoptotic cells and the blockade of cell cycle progression in S-phase and G2/M-phase. The presence of apoptosis in EPA-supplemented cultures was further confirmed by DNA fragmentation and ultrastructural changes associated with apoptosis. Therefore, we conclude that EPA mediates its effect on the pancreatic cancer cell line MIA PaCa-2, at least in part, via cell cycle arrest and the induction of apoptosis.
Pancreatic cancer is currently the fifth most common cause of cancer death in the Western world. Despite recent improvements in diagnosis and staging, the prognosis remains poor with a median survival of 3-6 months (Carter, 1989) . Unfortunately, surgical resection is rarely feasible, since most patients present with advanced inoperable disease. Although some groups have demonstrated slightly improved survival with conventional cytotoxic chemotherapy (Palmer et al., 1994) , there is, at present, no effective treatment for advanced pancreatic cancer. There is, therefore, a need to develop selective and relatively non-toxic treatment regimens directed at reducing the morbidity and mortality associated with pancreatic cancer.
In a number of experimental systems, certain polyunsaturated fatty acids (PUFAs) have been shown to have either a positive or negative influence (Holley et al., 1974; Hudson et al., 1993) on the growth of various tumour cell lines. The n-3 PUFA eicosapentaenoic acid (EPA) has potential as both an immunomodulator (Calder et al., 1991; Tate et al., 1988; DeMarco et al., 1994; Soyland et al., 1994) and as a direct anti-neoplastic agent (Hudson et al., 1993; Beck et al., 1991; Tisdale and Beck, 1991) . We have previously examined the action of a variety of fatty acids on the growth of three human pancreatic cancer cell lines (MIA PaCa-2, PANC-1 and CFPAC). These studies demonstrated that, at concentrations of fatty acids ranging from 5 to 50 ,uM, EPA was one of the most effective inhibitors of cell growth (Falconer et al., 1994) . Studies with mice bearing the MAC-16 colon adenocarcinoma have demonstrated a marked inhibition of both tumour growth rate and associated cachexia following dietary supplementation with EPA Tisdale and Dhesi, 1990) . However, the exact mechanism of these observed effects is not clear. Mechanisms which may explain the inhibition of tumour growth by EPA have included increased lipid perodixation (Begin et al., 1986; Lystad et al., 1994) or eicosanoid-mediated cytotoxicity (Minoura et Buckman et al., 1991) . It is also not known whether EPA exerts its effects by a reduction in cell proliferation or an increase in cell death.
Cell death following exposure to EPA may be the result of necrosis, apoptosis or a combination of the two. Necrosis is the classical form of cell death characterised by membrane breakdown, loss of ion transport, cell swelling and lysis giving rise to an inflammatory response in vivo. Apoptosis (programmed cell death), on the other hand, is a programmed series of cellular events, whereby the cell ceases cell division and packages its internal components for removal without evoking an inflammatory response (Wylie et al., 1980) . The main features of apoptosis may vary depending on cell type but often include cell shrinkage, formation of apoptotic bodies, DNA fragmentation owing to activation of endogenous endonucleases (Arends and Wylie, 1991; Cohen and Duke, 1984; Cohen, 1991) and the appearance of sub G1 or hypodiploid peaks on flow cytometric DNA analysis (Bryson et al., 1994; Telford et al., 1994) .
This study examines the mechanisms of growth inhibition by EPA on the pancreatic cancer cell line MIA PaCA-2. We describe the induction of cell cycle arrest and apoptosis in MIA PaCa-2 upon exposure to EPA in vitro.
Materials and methods Reagents Palmitic acid (PA), eicosapentaenoic acid (EPA), fatty acidfree bovine serum albumin (BSA) and propidium iodide were purchased from Sigma (Sigma, Poole, Dorset, UK). Fatty acids were complexed to BSA according to the method described previously (Falconer et al., 1994) (Falconer et al., 1994) to have no effect on the growth of pancreatic cancer cell lines, was chosen as a control fatty acid. BSA was also used as another control as both PA and EPA used in the experiments were albumin complexed. Parallel cultures were harvested at 24, 48 and 72 h after supplementation with BSA or fatty acids. All cells (adherent and non-adherent) were collected and resuspended in phosphate-buffered saline (PBS) (pH 7.2) before determining the cell number and viability with propidium iodide exclusion on a Coulter XL flow cytometer (Coulter Electronics, Luton, UK). Briefly, to 1 ml of cell suspension 100 jil of 0.025% propidium iodide solution was added 10 min before analysis and samples were analysed where non-viable cells were read as those cells positive for propidium iodide. The cell count and viability were also assessed using trypan blue exclusion under a microscope. Electron microscopy Cells were trypsinised from flasks, washed by centrifugation in PBS and the cell pellets fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer. Cell pellets were processed as described previously (Middleton et al., 1992 Effect of EPA on cell morphology and ultrastructure On inspection of cell cultures using phase-contrast microscopy, the cells grown in medium without supplement or in medium supplemented with BSA or PA (Figure 3a) had formed an adherent monolayer, while a proportion of those grown in EPA ( Figure 3b ) were round and shrunken, a feature suggestive of detachment from the surface of the culture flask. These features were most obvious in cells grown in medium supplemented with 50 jgM EPA (Figure 3b ), but were also observed in cultures containing 30 gM and 10 jiM EPA (data not shown). In addition there were variable amounts of vesicles in the cytoplasm of cells grown in the presence of EPA as well as vesicles in close proximity to both the cell membrane and the nuclear membrane (Figure 3b ). Ultrastructural changes associated with apoptosis were observed (Figure 4a, b and c) with the earliest indicators of apoptosis being slight nuclear margination and small coarse aggregates of chromatin throughout the nucleus. There were pronounced changes in nucleolar organisation with the appearance of condensed aggregates of chromatin around the periphery and within the nucleolus (Figure 4a ). The cytoplasm and cytoplasmic organelles showed no changes in morphological appearance, although large globules were occasionally seen within the cytoplasm of cells grown in the presence of EPA (Figure 4b) Figure 6 . In cells exposed to PA at 30 yM or 50 gM, there was a progressive increase in the proportion of cells in Go/G, phase (Figure 6a ) and a progressive decrease in the proportion of cells in S-phase (Figure 6b ), while the proportion of cells in G2/M-phase remained static throughout the time of culture (Figure 6c ). There was no obvious hypodiploid or sub G, peak present.
For cells exposed to EPA at 30 gM, a different pattern was observed in that the proportion of cells in Go/G, did not increase to the same degree as the PA-supplemented group (Figure 6a ) and the proportion of cells in S-phase did not decrease (Figure 6b ) to the same degree as the PAsupplemented group. The proportion of cells in GO/M-phase followed a similar pattern to those supplemented with PA (Figure 6c) . At an EPA concentration of 50 gM, there was an even further reduction in the proportion of cells in GO/GI phase (Figure 6a ), while the proportion of cells in S-phase remained unchanged (Figure 6b ). The proportion of cells in G2/M-phase again remained static (Figure 6c ).
Discussion
EPA has previously been shown to inhibit the growth of pancreactic cancer cell lines (Falconer et al., 1994 ). In the current study, we have observed similar inhibitory effects with EPA supplementation. When MIA PaCa-2 cells were exposed to EPA at 30 gM and 50 gM, there was a significant reduction in the total cell number as well as in the viability of cells ( Figure I a  and b) . The growth inhibition and cytotoxic effect were both time-and concentration-dependent. Furthermore, by using the propidium iodide exclusion method, we can identify a distinct population of apoptotic cells (Figure 2c and e) in cultures supplemented with EPA, which are distinct from the The propidium-dim cells may represent the early stages of apoptosis where the cell membrane can still exclude propidium but reduced repair mechanisms allow trapping of propidium in pits on the cell surface membrane. The presence of dead cells in the two-parameter plots (Figure 2a , c and e) represent those cells in the very late stages of apoptosis with reduced size, which can no longer exclude propidium iodide (Arends and Wylie, 1991; Telford et al., 1994; Bryson et al., 1994) .
The presence of apoptotic cells can also be demonstrated in DNA histograms by the appearance of a sub GI peak, which is an established indicator of apoptosis (Bryson et al., 1994; Telford et al., 1994) . In cells exposed to 50 gM EPA for 72 h, there was a sub GI peak, which compromised approximately 11% of the population ( Figure 5 ). Apoptosis was further confirmed in cells exposed to EPA by the distinctive morphological and ultrastructural changes of apoptosis (Figure 4a to d) , and by the presence of laddering on ethidium-stained DNA gels (Figure 4e ) (Cohen, 1991) . This is, therefore, the first demonstration that EPA can induce apoptosis in pancreatic tumour cells. (Karmali et al., 1984 (Karmali et al., , 1989 ). This hypothesis is not supported by the observation that cyclooxygenase inhibitors like indomethacin are unable to influence the growth of tumour cells in vivo (Feldman and Hilf, 1985; Abou-El-Ela et al., 1989) . In addition, the effects of indomethacin on various in vitro models show that it can either stimulate or inhibit tumour cell proliferation (Buckman et al., 1991; Fulton, 1984; Rose and Connolly, 1990; Bayer et al., 1979; Hial et al., 1977) . Other studies have suggested that increased lipid peroxidation may be an important cause of cytotoxicity associated with n-3 PUFAs but a definite role has not been established (Falconer et al., 1994; Lystad et al., 1994) .
Various reports in the literature have shown a link between cell surface receptors and their associated kinases and the induction of apoptosis (Kleinman et al., 1994; Spinozzi et al., 1994) . Most of the incorporated EPA appears to remain in the phospholipid component of cell membranes (Brown and Subbaiah, 1994) , although the cytoplasmic lipid accumulation observed in the present study may suggest that other mechanisms are also important. However, it has been shown that the relative quantity of polyunsaturated fatty acids in the cell membrane may play an important role in regulation of proliferation and cellular functions (Brown and Subbaiah, 1994; Pan et al., 1990; Bandyophadhyay et al., 1993) . It is possible that EPA may alter the microenvironment of surface receptors or signalling proteins in the cell membrane, thereby inducing inappropriate signalling moieties and initiating cell cycle arrest and apoptosis.
Further experimental work on the pharmacokinetics of EPA, mode of delivery to the tumour and mechanism of EPA-induced apoptosis will provide information which will be useful in designing regimens for the treatment of pancreatic cancer.
